(Q36725202)

15 August 2017

1 reference

title

Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury (English)

1 reference

15 August 2017

1 reference

Yi-Shin Huang

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Expert Opinion on Drug Metabolism & Toxicology

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

1-8

1 reference

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Activation of procarcinogens by human cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Glutathione S-transferase: genetics and role in toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

A study to survey susceptible genetic factors responsible for troglitazone‐associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.1.1

21 January 2018

Identifiers

DOI

10.1517/17425255.3.1.1

1 reference

15 August 2017

1 reference